UB launches the Cancer Research Consortium

UB faculty have 97 active cancer research grant awards totaling more than $7 million

Release Date: December 16, 2020

Print
Headshot of Roberto Pili.

Roberto Pili, MD, associate dean for cancer research and integrative oncology, and chief, Division of Hematology/Oncology in the Department of Medicine

“In his role as associate dean, Pili will be building an academic infrastructure for innovative and collaborative cancer research at UB with our partners on the Buffalo Niagara Medical Campus and beyond. ”
Michael E. Cain, MD, Vice president for health sciences and dean, Jacobs School of Medicine and Biomedical Sciences

BUFFALO, N.Y — The University at Buffalo is home to a rich and growing portfolio of innovative, externally funded cancer research projects across multiple academic units.

That was the message of the first meeting of the UB Cancer Research Consortium, held virtually on Dec. 10, where it was reported that faculty are working on 97 active cancer research awards totaling $7.4 million in annual direct funding.

“Those awards give us a snapshot of the existing breadth and depth of cancer research at UB,” said Roberto Pili, MD, associate dean for cancer research and integrative oncology, and chief of the Division of Hematology/Oncology in the Department of Medicine, who moderated the meeting. He noted that of that total, $3.5 million represents the annual direct funding by the National Cancer Institute of the National Institutes of Health, which he called “remarkable.”

Plans are underway for a two-day symposium on cancer research to be hosted by UB in the summer of 2021.

During last week’s half-day meeting, 10 UB faculty members presented their research. Topics ranged from smoking and DNA methylation in the lungs, and cancer risk and obesity to the gene regulatory network of oral squamous cell carcinoma and drug-delivery strategies in pancreatic cancer.

Strong collaborations

Pili, who has a secondary appointment in the Department of Exercise and Nutrition Sciences, noted that a chief strength of cancer research at UB are the multidisciplinary collaborations in the School of Public Health and Health Professions, the Jacobs School of Medicine and Biomedical Sciences, the School of Dental Medicine, the School of Pharmacy and Pharmaceutical Sciences, the School of Nursing, the College of Arts and Sciences, and the School of Engineering and Applied Sciences.

He said that additional opportunities exist at UB for strong collaborations in immunotherapies, epigenetics, drug discovery delivery, lifestyle dietary interventions and other cancer research areas.

The meeting began with a welcome by Michael E. Cain, MD, vice president for health sciences and dean of the Jacobs School, and Jean Wactawski-Wende, PhD, dean of the School of Public Health and Health Professions and SUNY Distinguished Professor in the Department of Epidemiology and Environmental Health.

“In his role as associate dean, Pili will be building an academic infrastructure for innovative and collaborative cancer research at UB with our partners on the Buffalo Niagara Medical Campus and beyond,” said Cain, who added that Pili also serves as vice president for oncology services at Great Lakes Cancer Care Collaborative.

“Cancer remains a leading cause of morbidity and mortality across world,” said Wactawski-Wende. “We have such a richness of opportunity at UB to explore cancer further.”

She added that Pili’s expertise in nutrition and cancer provides an important complement to UB’s existing research strengths. Pili is the inaugural director of UB’s new Sciences, Nutrition and Cancer (SNAC) Center in the Jacobs School, which will constitute a building block to establish a program for integrative oncology, where dietary interventions, exercise and mind-body medicine will be integrated into cancer patient care.

Media Contact Information

Ellen Goldbaum
News Content Manager
Medicine
Tel: 716-645-4605
goldbaum@buffalo.edu
Twitter: @UBmednews